Physical Activity Barriers in AECOPD

NCT04162392 | Unknown

• 1 other identifier: DF0084UG
• Study Type: interventional
• Target: 40
• Locations: 0 countries
• Sites: N/A

Brief Summary

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Patients require good communication with the physician to improve control illness. Shared decision making is a good option to improve physical activity barriers in acute exacerbated COPD patients during the hospitalization period.

Conditions

COPD Exacerbation

Outcome Measures

Primary Outcomes (3)

• Health related quality of life: EQ-5D

  European Quality of Life questionnaire consists of the EQ-5D visual analog scale and the EQ-5D index. The visual analog scale has a rating scale of 0-100 (0 worst possible health, and 100 best possible health). The questionnaire has 5 domains: mobility, self-care, usual activity, pain, and anxiety-depression. For each item, the subject selects one of 3 descriptive health states (from good to poor).

  Participants will be followed for the duration of hospital stay, an expected average of 9 days and after discharge 3 months follow up

• Functional capacity

  The International Physical Activity Questionnaire (IPAQ) short form measures walking, moderate- and vigorous intensity, and total PA and daily time spent sitting on weekdays. PA was reported in MET·minutes/week and days per week and was scored using standardized IPAQ scoring protocols to yield total metabolic equivalent minutes (MET·minutes/week) of PA per week. Sitting time was reported as the amount of time in hours and/or minutes participants spent sitting on a weekday during the past seven days.

  Participants will be followed for the duration of hospital stay, an expected average of 9 days and after discharge 3 months follow up

• Barriers to Being Active Quiz

  The Barriers to Being Active Quiz is a 21-item scale that provides a measure of 7 self-reported barriers to being physically active.This instrument uses a 4-point Likert scale for individuals to identify if they would say or think any of the statements would be true for them, with 0 being very unlikely to 3 being very likely. Per instrument instructions, each barrier has 3 items that are summed for scoring, with a range of 0 to 9 for each.

  Participants will be followed for the duration of hospital stay, an expected average of 9 days and after discharge 3 months follow up

Study Arms (2)

Experimental group

EXPERIMENTAL

Other: shared decision making

Control group

ACTIVE COMPARATOR

Other: control group

Interventions

shared decision making OTHER

Patients can choose the intervention that they want. There are different physiotherapy interventions were the patients have to do physical activity during the hospital stay. The physiotherapist explains the advantages and disadvantages of each treatment before they choose.

Experimental group

control group OTHER

Patients receive a physiotherapy intervention but they do not have the opportunity to choose the treatment

Control group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

Sponsors & Collaborators

• Universidad de Granada: lead

MeSH Terms

Interventions

Control Groups

Intervention Hierarchy (Ancestors)

Epidemiologic Research Design; Epidemiologic Methods; Investigative Techniques; Research Design; Methods

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal investigator

Study Record Dates

• First Submitted: November 11, 2019
• First Posted: November 14, 2019
• Study Start: December 1, 2019
• Primary Completion: April 1, 2020
• Study Completion: August 1, 2020
• Last Updated: November 14, 2019

Record last verified: 2019-11